• Market Pulse
  • Week On-chain
  • Strategy Watch
  • Partner Reports
  • Product & Research
  • Subscribe
  • Log In
  • English
  • Español
  • Français
  • Italiano
  • Polski
  • Português
  • Türkçe
  • русский
  • Ελληνικά
  • עברית
  • فارسی
  • عربي
  • 中文
  • 日本語
  • Tiếng Việt
Glassnode Research – Digital Asset Market Intelligence
  • Market Pulse
  • Week On-chain
  • Strategy Watch
  • Partner Reports
  • Product & Research
  • Log In
Market Vectors

The Altcoin Vector #37

This week's professional-grade insights into crypto's most volatile frontier. Identify high-conviction setups across altcoin markets with this exclusive weekly report.

  • Glassnode

Glassnode, Swissblock

Jan 14, 2026 • 1 min read
The Altcoin Vector #37

Executive Summary

Already a subscriber? Log in

Recommended Posts

Anatomy of a Liquidity Freeze

Anatomy of a Liquidity Freeze

A forged LayerZero message drained 116,500 rsETH from Kelp DAO. The attacker's collateral loop on Aave triggered the largest confidence-driven liquidity event in the protocol's history. WETH available liquidity fell from $689M to $1.5M in two hours.
Apr 27, 2026 11 min read
Mean Reclaimed, Rally on Trial

Mean Reclaimed, Rally on Trial

BTC reclaims $78k as spot demand and ETF inflows return. Shorts build with negative funding, creating squeeze potential. Yet elevated realized profits and soft volatility signal caution, with upside near $80k facing resistance.
Apr 22, 2026 10 min read
Expanding Glassnode: Macro and Traditional Finance Data
Featured

Expanding Glassnode: Macro and Traditional Finance Data

Glassnode is expanding its data coverage to include macro and TradFi metrics, enabling users to contextualize digital asset markets within broader financial conditions.
Apr 16, 2026 5 min read
Glassnode Research – Digital Asset Market Intelligence © 2026
  • Terms and Conditions
  • Privacy Notice
  • Contact Support
Powered by Ghost

Subscribe for free to receive best-in-class market analysis on Bitcoin, Ethereum, and DeFi, and novel on-chain research.

By subscribing, you agree to our Terms & Conditions and Privacy Notice.

Thank you for subscribing.